Home Procalcitonin measurement in routine emergency medicine practice: comparison between two immunoassays
Article
Licensed
Unlicensed Requires Authentication

Procalcitonin measurement in routine emergency medicine practice: comparison between two immunoassays

  • Pierre Hausfater , Christine Brochet , Yonathan Freund , Vanessa Charles and Maguy Bernard
Published/Copyright: February 12, 2010

Abstract

Background: Accurate identification of bacterial infections in patients presenting at the emergency department is crucial for early and rational antibiotic treatment. In this situation, using a cut-off of 0.25 μg/L for procalcitonin allows for carefully monitoring of febrile patients. Most previous studies have been performed with the reference B·R·A·H·M·S PCT KRYPTOR® assay. The goal of this study was to compare this test with the VIDAS B·R·A·H·M·S PCT® assay and to validate clinically relevant cut-off thresholds.

Methods: This prospective study was conducted in adults presenting to the emergency departments of a tertiary hospital. We included 305 consecutive patients that had procalcitonin requested. Procalcitonin was measured first with the KRYPTOR, then with the VIDAS systems. Statistical analysis consisted in Passing and Bablok and Bland-Altman plots.

Results: In the overall cohort, 176 patients had procalcitonin concentrations measured using both methods and were well correlated. The Bland-Altman plot exhibited a bias of 0.108 [95% confidence interval: –0.044 to 0.260]. The concordance at different procalcitonin cut-off thresholds, respectively of 0.1, 0.25, 0.5 and 2 μg/L, indicated that above 0.25 μg/L, the κ coefficient was >0.80.

Conclusions: A highly significant correlation was observed between the two automated assays. Procalcitonin concentrations obtained from both methods led to the same clinical interpretation.

Clin Chem Lab Med 2010;48:501–4.


Corresponding author: Maguy Bernard, UF d'Oncobiochimie et Biochimie prénatale, GH Pitié-Salpêtrière, 47–83, bd de l'Hôpital, 75013 Paris, France Phone: +33 (0) 1 42 16 21 86, Fax: +33 (0) 1 42 16 20 33,

Received: 2009-9-18
Accepted: 2009-11-20
Published Online: 2010-02-12
Published in Print: 2010-04-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorials
  2. Molecular biology and genetics in clinical chemistry and laboratory medicine
  3. Improving the post-analytical phase
  4. Reviews
  5. State of the art in therapeutic drug monitoring
  6. Decision criteria for rational selection of homogeneous genotyping platforms for pharmacogenomics testing in clinical diagnostics
  7. Reference Values and Biological Variations
  8. Assessment of critical values policies in Italian institutions: comparison with the US situation
  9. Genetics and Molecular Diagnostics
  10. Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C virus genotyping
  11. Genotyping mitochondrial DNA single nucleotide polymorphisms by PCR ligase detection reactions
  12. FOXL2 mutations in Taiwanese patients with blepharophimosis, ptosis, epicanthus inversus syndrome
  13. Low expression of human β-defensin 1 in duodenum of celiac patients is partially restored by a gluten-free diet
  14. General Clinical Chemistry and Laboratory Medicine
  15. Evaluation of C-reactive protein and serum amyloid A in the detection of inflammatory and infectious diseases in children
  16. Procalcitonin measurement in routine emergency medicine practice: comparison between two immunoassays
  17. Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer
  18. Simultaneous determination of serum tryptophan metabolites in patients with systemic lupus erythematosus by high performance liquid chromatography with fluorescence detection
  19. Beware of carryover in modern chemistry analyzers
  20. Correlation between glucose and bupivacaine levels in cerebrospinal fluid after spinal anesthesia: glycorrhachia as predictor for duration of sensory block
  21. Comparison of different depletion strategies for improving resolution of the human urine proteome
  22. Cardiovascular Diseases
  23. Pregnancy-associated plasma protein-A as a marker for long-term mortality in patients with peripheral atherosclerosis: inconclusive findings from the Linz Peripheral Arterial Disease (LIPAD) study
  24. Association of matrix metalloproteinase 9 genotypes and cardiovascular disease risk factors with serum matrix metalloproteinase 9 concentrations in Taiwanese individuals
  25. C-reactive protein variants are not associated with susceptibility to stroke and stroke recurrence
  26. Association of hyperhomocysteinemia with left ventricular dilatation and mass in human heart
  27. A methodological reappraisal of total and high molecular weight adiponectin determination in human peripheral circulation: comparison of four immunometric assays
  28. Letters to the Editor
  29. High specificity but low sensitivity of the cartilage oligomeric matrix protein (COMP) test in rheumatoid arthritis and osteoarthritis
  30. Disparity in estimated average glucose due to different hemoglobin A1c methods and hemoglobin S trait
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.091/html
Scroll to top button